Growth at Reasonable Price

Results

631

631 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
INR
US$14.676.7%7.2%US$915.2mUS$22.635.458.2%n/aEnergy
3036
NT$206.00-1.9%68.2%NT$261.1bNT$314.8610.728.9%3.8%Tech
MDGL
US$519.092.3%25.2%US$12.0bUS$678.069.363.7%n/aPharmaceuticals & Biotech
TGTX
US$50.565.5%75.7%US$7.3bUS$69.7116.221.3%n/aPharmaceuticals & Biotech
RHM
€1,162.20-0.2%-27.7%€54.2b€1,679.3844.830.5%1.0%Capital Goods
AXSM
US$208.03-2.6%75.5%US$10.9bUS$285.4214.061.1%n/aPharmaceuticals & Biotech
NVDA
US$216.85-3.8%23.9%US$5.3tUS$304.1232.922.9%0.5%Semiconductors
MOD
US$190.74-6.3%41.4%US$10.4bUS$310.2970.351.3%n/aCapital Goods
7685
JP¥3,190.000.8%83.6%JP¥206.5bJP¥4,866.6726.826.6%0.8%Retail
2368
NT$963.00-5.1%109.8%NT$524.7bNT$1,554.4434.242.6%1.0%Tech
001389
CN¥155.95-8.0%124.7%CN¥70.1bCN¥251.6749.834.4%0.4%Tech
601567
CN¥14.84-2.9%-36.6%CN¥21.1bCN¥35.7721.845.6%4.2%Capital Goods
SNDX
US$19.753.5%24.7%US$1.9bUS$37.917.069.5%n/aPharmaceuticals & Biotech
CAMX
SEK 630.00-0.7%-8.9%SEK 37.5bSEK 793.0055.335.9%n/aPharmaceuticals & Biotech
AAUC
CA$31.66-0.8%74.0%CA$4.5bCA$41.702.141.8%n/aMaterials
2313
NT$212.50-1.4%186.4%NT$259.2bNT$316.0034.242.4%1.3%Tech
6805
NT$1,775.00-1.7%70.7%NT$126.8bNT$2,420.1038.037.9%0.6%Tech
285A
JP¥54,200.000.9%2,155.5%JP¥29.0tJP¥111,431.2521.528.4%n/aSemiconductors
002518
CN¥33.38-5.7%-5.9%CN¥19.1bCN¥58.6830.431.2%1.3%Capital Goods
300308
CN¥943.000%238.1%CN¥1.1tCN¥1,304.0573.851.2%0.1%Tech
RSG
AU$1.3419.1%81.1%AU$2.7bAU$1.8610.334.8%0%Materials
000893
CN¥47.374.5%49.2%CN¥43.7bCN¥70.0023.836.5%0.2%Materials
600733
CN¥5.06-4.5%-46.1%CN¥33.2bCN¥7.441.184.4%n/aAutomobiles
PICS
US$10.05-11.9%n/aUS$1.4bUS$19.955.823.3%n/aDiversified Financials
Page 1 of 18
Growth at Reasonable Price - Investing Ideas - Simply Wall St